- Metabolite
- HMDB0011620 (Arsenite)
- Biospecimen
- Cerebrospinal Fluid (CSF)
- Status
- Detected and Quantified
- Data source
- Referenced
- Concentration
- 0.095 (0.0035-0.31) uM
- Age
- Adult (>18 years old)
- Sex
- Both
- Condition
- Acute promyelocytic leukemia (APL)
Comments
Patients with Acute promyelocytic leukemia (APL) on oral arsenic trioxide.
References
- Au WY, Tam S, Fong BM, Kwong YL: Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy. Blood. 2008 Nov 1;112(9):3587-90. doi: 10.1182/blood-2008-06-161000. Epub 2008 Aug 14. [PubMed:18703707 ]